0 Freeze-dried polio vaccine could avoid cold chain issues
Researchers have developed a freeze-dried polio vaccine that doesn’t require refrigeration and is still efficacious after rehydration.
Browsing: Clinical > Vaccines
0 Merck cuts back on rotavirus vaccine commitment to West Africa: November’s industry headlines
Positive results for zoliflodacin, EMA approval for fexinidazole and Merck cuts rotavirus commitment – take a look a the month’s industry headlines.
0 FDA grants priority review for controversial dengue vaccine, Dengvaxia
The US FDA has granted priority review for Sanofi Pasteur’s dengue vaccine, Dengvaxia®, despite its controversial past.
0 Oral cholera vaccination to be administered to 1.4 million in Zimbabwe’s capital
The WHO are amongst those aiding the Government of Zimbabwe to begin an oral cholera vaccination campaign yesterday, in efforts to immunize 1.4 million people living in high-risk regions in Harare, the capital of Zimbabwe.
0 Rotavirus vaccination has reduced infant deaths in Malawi by a third
The first population-level evidence has proved the rotavirus vaccination saves lives in low-income settings.
0 Ebola vaccination initiated in North Kivu
Vaccination has begun to try and contain the second outbreak of Ebola seen in the Democratic Republic of Congo this year.
0 Can the human microbiome influence rotavirus vaccine response?
New study finds that the oral rotavirus vaccine response could be influenced by changes in the human microbiota.
0 UK committee recommends HPV vaccinations for adolescent boys
The Joint Committee on Vaccination and Immunisation has stated that a gender-neutral vaccine program would be cost effective in the UK and would protect boys against HPV infection and associated diseases.
0 Shigellosis – an update on the vaccine pipeline
Globally, shigella is reported to be the third largest cause of diarrheal mortality in the under-fives. We take a look at some of the vaccines that have made it to clinical development and some of the challenges still facing this diarrheal disease.
0 The APPROACH clinical trial produces positive results with a mosaic HIV-1 vaccine
Experimental HIV-1 vaccine regimen is safe and elicits a robust immune response according to results of a Phase I/IIa clinical trial.
